Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D001095:Arachidonic Acids / Q000097:blood / Q000494:pharmacology*; D001792:Blood Platelets / Q000378:metabolism*; D016861:Cyclooxygenase Inhibitors; D004837:Epinephrine / Q000494:pharmacology; D006801:Humans; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D010974:Platelet Aggregation / Q000187:drug effects*; D011448:Prostaglandin Antagonists / Q000494:pharmacology*; D011458:Prostaglandins E / Q000096:biosynthesis; D011463:Prostaglandins H / Q000494:pharmacology; D011956:Receptors, Cell Surface / Q000378:metabolism*; D011982:Receptors, Prostaglandin / Q000378:metabolism*; D013928:Thromboxane A2 / Q000494:pharmacology; D013929:Thromboxane B2 / Q000096:biosynthesis; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*
D001095:Arachidonic Acids; D016861:Cyclooxygenase Inhibitors; D011448:Prostaglandin Antagonists; D011458:Prostaglandins E; D011463:Prostaglandins H; D011956:Receptors, Cell Surface; D011982:Receptors, Prostaglandin; D013929:Thromboxane B2; D013928:Thromboxane A2; D000244:Adenosine Diphosphate; D010088:Oxidoreductases; D013930:Thromboxane-A Synthase; D004837:Epinephrine